INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 412m ago
HOUSE PTR12m ago
SEC 13F12m ago
ROBINHOOD CHAIN12m ago
FR
Corporate insider

Fenimore Christopher R.

EVP Finance CFOCIK 0001697422

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score26
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Gift
G—
15 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.EVP Finance CFO · Aug 20, 2026
26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Tax withholding
F
$4.03M
4,243 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.29M
6,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
6,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.40M
6,283 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

9
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
6,283 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Tax withholding
F$3.74M
4,599 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence